References
Pereira MP, Steinke S, Zeidler C, et al. European academy of dermatology and verereology European prurigo project: expert consensus on the definition, classification and terminology of chronic prurigo. J Eur Acad Dermtol Venereol 2018; 32: 1059–65.
Zeidler C, Tsianakas A, Pereira M, Stander H, Yosipovitch G, Stander S. Chronic prurigo of nodular type: a review. Acta Derm Venereol 2018; 98: 173–9.
Ito Y, Satoh T, Takayama K, Miyagishi C, Walls AF, Yokozeki H. Basophil recruitment and activation in inflammatory skin diseases. Allergy 2011; 66: 1107–13.
Agis H, Krauth MT, Bohm A, et al. Identification of basogranulin (BB1) as a novel immunohistochemical marker of basophils in normal bone marrow and patients with myeloproliferative disorders. Am J Clin Pathol 2006; 125: 273–81.
Strunk RC, Bloomberg GR. Omalizumab for asthma. N Engl J Med 2006; 354: 2689–95.
Yamaguchi M, Koketsu R, Suzukawa M, Kawakami A, Iikura M. Human basophils and cytokines/chemokines. Allergol Int 2009; 58: 1–10.
Mukai K, Matsuoka K, Taya C, et al. Basophils play a critical role in the development of IgE–mediated chronic allergic inflammation independently of T cells and mast cells. Immunity 2005; 23: 191–202.
Hashimoto T, Satoh T, Yokozeki H. Protective role of STAT6 in basophil–dependent prurigo–like allergic skin inflammation. J Immunol 2015; 194: 4631–40.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Ugajin, T., Inazawa, M., Inui, K. et al. A case of chronic prurigo successfully treated with omalizumab. Eur J Dermatol 28, 691–692 (2018). https://doi.org/10.1684/ejd.2018.3351
Published:
Issue Date:
DOI: https://doi.org/10.1684/ejd.2018.3351